In the News
Deepali Sachdev, PhD, a breast cancer researcher with the Masonic Cancer Center and the University of Minnesota Medical School, as recently awarded a research grant by METAvivor.
- Presented by 2019 NYFW + #Cancerland in memory of Champagne Joy - Deepali Sachdev, BSc,MSc, PhD Regents University - Development of natural killer cell based tri-specific killer engagers (TriKEs) as novel immunotherapy for metastatic breast cancer -
Rein in Sarcoma proudly announces a $150,000 research grant approved by the Rein in Sarcoma Board on January 27, 2020. This brings the cummulative research funding by Rein in Sarcoma to $2 million since the organization’s founding in 2001. All proposals were reviewed though a central electronic review system and had three external reviewers for each proposal following NIH scoring procedures. Based on their review and the UMN Faculty recommendations, the RIS Research Task Force brought forward three proposals for RIS Board approval.
Senescent cells — also known as “zombie cells” because they’re damaged and unable to die — are tied to many age-related diseases.
11:46 AM Eastern Daylight Time
Newswise — ROCHESTER, Minn. — A statewide bipartisan initiative is transforming health care from a focus on treating disease to one of tapping the body's ability to heal itself. Regenerative Medicine Minnesota is a legislative initiative aimed at improving health by advancing regenerative medicine in research, technology, education and patient care across the state.
MOCA celebrated 20 years of progress – and new milestones in ovarian cancer research funding – at the MOCA Annual Meeting this week.
This year, MOCA awarded $680,000 in funding to Minnesota and national researchers, putting our total amount of funding at nearly $9 million.
The 2019 MOCA-funded researchers at the Masonic Cancer Center, University of Minnesota include:
